Serum Estradiol/Progesterone Ratio on Day of Embryo Transfer May Predict Reproductive Outcome

Article

Serum Estradiol/Progesterone Ratio on Day of Embryo Transfer May Predict Reproductive OutcomeFollowing Controlled Ovarian Hyperstimulation and In vitro Fertilization

Journal of Experimental & Clinical Assisted Reproduction Vol. 4
An Open Access Article
Published 19 March 2007

Abstract (provisional)
Hypothesis

Background
To determine whether estradiol-to-progesterone (E2/P) ratios at the time of embryo transfer (ET) have an effect on implantation and pregnancy in IVF cycles.

Methods
239 women consecutively treated by IVF or ICSI were retrospectively analyzed and early luteal serum E2 and P were measured on the day of ET. Transfer occurred after a variable in vitro culture period ranging from 4-7 days after ovulation induction (OI). Following ET, serum E2/P ratios were calculated for clinical pregnancies, preclinical abortions and non-coneption cycles.

Results
Receiver-operator curve analysis demonstrated that the E2/P ratio could differentiate between clinical pregnancies and non-pregnant cycles (area under the curve on OI +4 days = 0.70; 95% CI = 0.60-0.80; p=0.003, on OI +5 days = 0.76; 95% CI = 0.64-0.88; p=0.001, OI +7 days =0.85; 95% CI = 0.75-0.96; p<0.0001).

Conclusions
These retrospective data may hold prognostic value regarding endometrial receptivity as reflected by E2/P measurements and may help improve IVF treatment outcome. Further prospective studies should be undertaken to confirm these observation.

References:

Journal of Experimental & Clinical Assisted Reproduction 2007, 4:1 doi:10.1186/1743-1050-4-1

complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

Recent Videos
raanan meyer, md
Fertility counseling for oncology patients | Image Credit: allhealthtv.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
The importance of maternal vaccination | Image Credit: nfid.org.
Haywood Brown, MD | Image credit: © USF Health
Beth Garner, MD, MPH
Related Content
© 2024 MJH Life Sciences

All rights reserved.